Journal of Investigative Medicine High Impact Case Reports (Nov 2014)

Histological Regression of Giant Cell Tumor of Bone Following RANK Ligand Inhibition

  • Martin F. Dietrich MD, PhD,
  • Dominick Cavuoti MD,
  • Michael Landay MD,
  • Yull E. Arriaga MD

DOI
https://doi.org/10.1177/2324709614560216
Journal volume & issue
Vol. 2

Abstract

Read online

Lung metastases are a rare complication of giant cell tumors of bone. We herein describe an interesting case of histological regression and size reduction of lung metastases originating from a primary giant cell tumor of bone in response to the RANK ligand inhibitor denosumab.